Changes could be on the way for Canada’s cannabis regulations, Health Canada’s Special Access Program

Growth op

On Friday, Health Canada announced a 30-day consultation period is now underway that could lead to changes for cannabis research, product labelling, beverage limits, and more.  People are increasingly open to psychedelic therapies. What’s driving that change? Canadian researchers receive more than $4 million in funding to breed better cannabis Did Canada legalize weed before doing its research? According to the notice, Health Canada is considering streamlining and rationalizing the licensing framework to facilitate cannabis-based testing and will take steps to encourage further non-therapeutic cannabis research.  That could include studying the impact of cannabis use on driving performance, for example, and investigating the onset and duration of various cannabis products.  Product labelling requirements may also be expanded to include information about terpenes and other cannabinoids. Currently, product labels are required only to list information about the quantity or concentration of THC and CBD.  For small-scale growers, Health Canada is asking if there any elements of the regulatory framework that put micro-cultivation, micro-processing and nursery licence holders at a competitive disadvantage compared to larger companies.  The government is also asking for feedback on the current beverage limits, which are capped at two litres. The document notes that stakeholders have raised concerns that the confusing limits push consumers to higher-potency products.  Changes to Health Canada’s Special Access Program Additionally, the government announced its intent to amend the Food and Drug Regulations and the Narcotic Control Regulations to restore potential access to restricted drugs through Health Canada’s Special Access Program (SAP).  The SAP was designed to allow Canadians to access medicines that have not been formally approved but historically, psychedelic medications have not been eligible. That could soon change.  Revisions to the program could make it easier for Canadians to access drugs like MDMA and psilocybin (magic mushrooms) for therapeutic purposes.  This year…

Excerpt only …
Source : Changes could be on the way for Canada’s cannabis regulations, Health Canada’s Special Access Program

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.